Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endogenous mediators and thrombophilia

R E Smith1, J F Martin

  • 1Department of Medicine, King's College School of Medicine and Dentistry, London, UK.

Bailliere'S Clinical Haematology
|September 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expression of a synthetic copy of the bovine chymosin gene in Aspergillus awamori from constitutive and pH-regulated promoters and secretion using two different pre-pro sequences.

Biotechnology and bioengineering·2003
Same author

The two-component PhoR-PhoP system controls both primary metabolism and secondary metabolite biosynthesis in Streptomyces lividans.

Proceedings of the National Academy of Sciences of the United States of America·2003
Same author

The cefT gene of Acremonium chrysogenum C10 encodes a putative multidrug efflux pump protein that significantly increases cephalosporin C production.

Molecular genetics and genomics : MGG·2002
Same author

Nitrate regulation of alpha-aminoadipate reductase formation and lysine inhibition of its activity in Penicillium chrysogenum and Acremonium chrysogenum.

Applied microbiology and biotechnology·2002
Same author

Acute rise of circulating vascular endothelial growth factor-A in patients with coronary artery disease following cardiothoracic surgery.

European heart journal·2002
Same author

A reconsideration of the origins of the type 2 diabetes epidemic among Native Americans and the implications for intervention policy.

Medical anthropology·2002
Same journal

Current status of stem cell therapy and prospects for gene therapy for the disorders of globin synthesis.

Bailliere's clinical haematology·2000
Same journal

Pharmacological therapy.

Bailliere's clinical haematology·2000
Same journal

Prenatal diagnosis and screening of the haemoglobinopathies.

Bailliere's clinical haematology·2000
Same journal

Sickle cell disease: clinical management.

Bailliere's clinical haematology·2000
Same journal

Pathophysiology of sickle cell disease.

Bailliere's clinical haematology·2000
Same journal

Thalassaemia: clinical management.

Bailliere's clinical haematology·2000
See all related articles

Platelet function involves a balance of vascular mediators and platelet production. Nitric oxide (NO) is key in preventing platelet activation, and its dysfunction contributes to thrombotic states like myocardial infarction.

Area of Science:

  • Cardiovascular Biology
  • Hemostasis and Thrombosis
  • Endothelial Function

Background:

  • Platelet function is regulated by a balance between prothrombotic and antithrombotic factors.
  • Nitric oxide (NO), synthesized by the endothelium, is a critical inhibitor of platelet activation and a vasodilator.
  • Impaired or altered NO synthesis can lead to prothrombotic states.

Purpose of the Study:

  • To explore the role of nitric oxide in regulating platelet function.
  • To understand the interplay between nitric oxide, other mediators, and platelet reactivity.
  • To investigate changes in platelet characteristics during thrombotic conditions.

Main Methods:

  • Analysis of nitric oxide synthesis pathways (constitutive and inducible).
  • Examination of interactions between nitric oxide, prostacyclin, and thromboxane.

Related Experiment Videos

  • Evaluation of platelet size and reactivity in relation to megakaryocyte size in thrombotic states.

    • Main Results:

    • Nitric oxide acts synergistically with vasodilators like prostacyclin and is opposed by vasoconstrictors like thromboxane.
    • Pathological states can involve impaired or increased nitric oxide synthesis.
    • Larger, more reactive platelets derived from larger megakaryocytes are observed in thrombotic conditions such as myocardial infarction.

    Conclusions:

    • Nitric oxide plays a pivotal role in maintaining vascular hemostasis by inhibiting platelet activation.
    • Dysregulation of nitric oxide synthesis contributes to the development of thrombotic disorders.
    • Platelet characteristics, influenced by megakaryopoiesis, are altered in thrombotic states, highlighting a link between platelet origin and reactivity.